Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CCND2_RAT
REST API REST API
Rattus norvegicus
CCND2_RAT is differentially expressed in 30 experiments: 24 organism parts: cardiac ventricle muscle, cerebellum, ... (22 more);, 2 disease states: cardiac hypertrophy, normal;, 11 cell types 5 compound treatments 3 clinical treatments and 8 other conditions.
Orthologs ccnd2b (Danio rerio)   Ccnd2 (Mus musculus)   F6S8K9_CIOIN (Ciona intestinalis)   CCND2 (Homo sapiens)   CCND2_CHICK (Gallus gallus)   ccnd2a (Danio rerio)   CycD (Drosophila melanogaster)   ccnd2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term cytosol, cell division, protein binding, cytoplasm, positive regulation of cell proliferation, membrane, regulation of cyclin-dependent protein kinase activity, spermatogenesis, response to cAMP, regulation of neuron differentiation, regulation of cell cycle, protein kinase binding, G1/S transition of mitotic cell cycle, nucleus, cellular_component, chromatin, response to ethanol, nucleolus, nuclear membrane, cellular response to insulin stimulus, response to testosterone stimulus, positive regulation of epithelial cell proliferation, ovarian follicle development, response to peptide hormone stimulus, response to estradiol stimulus, positive regulation of cyclin-dependent protein kinase activity, liver development, cyclin-dependent protein kinase holoenzyme complex, positive regulation of protein phosphorylation, response to organic cyclic compound
InterPro Term Cyclin-like, Cyclin_N, Cyclin_C, Cyclin_A/B/D/E
UniProt Accession Q04827, Q6LC41
Search EB-eye ENSRNOG00000019939
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-142, E-GEOD-2270, E-GEOD-3952, E-GEOD-952, E-GEOD-471 ... (5 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-MEXP-31, E-GEOD-2499, E-GEOD-2032

Factor Value U/D Experiments
total testis
1
E-MEXP-31
Sertoli cell
1
E-MEXP-31
fibroblast
1
E-GEOD-2032
myoctye
1
E-GEOD-2032
astrocyte
1
E-GEOD-2499
spermatogonia
1
E-MEXP-31
5 more value(s).


Disease state

studied in E-GEOD-738

Factor Value U/D Experiments
cardiac hypertrophy
1
E-GEOD-738
normal
11
1
E-GEOD-738


Compound treatment

studied in E-MEXP-776, E-MEXP-1169, E-GEOD-1978

Factor Value U/D Experiments
none
17
1
E-MEXP-776
sulphated cholecystokinin-8
1
E-MEXP-1169
control
3
1
E-GEOD-1978
ethanol
1
E-MEXP-776
lacZ
1
E-GEOD-1978


Clinical treatment

studied in E-GEOD-738

Factor Value U/D Experiments
myocardial infarction
1
E-GEOD-738
aortic banding
1
E-GEOD-738
aortic banding - sham
1
E-GEOD-738


compound_treatment_design

studied in E-TABM-12

Factor Value U/D Experiments
17a-ethynylestradiol
1
E-TABM-12
bisphenol A
1
E-TABM-12
genestein
1
E-TABM-12


Developmental stage
studied in E-GEOD-4236, E-GEOD-903

Growth condition
studied in E-GEOD-6102, E-GEOD-1567

Material type
studied in E-GEOD-4192, E-GEOD-467

protocol
studied in E-GEOD-20895

Protocol type
studied in E-GEOD-691

Replicate
studied in E-GEOD-4192

Strain or line
studied in E-MEXP-776, E-GEOD-2116

Processing time: 1.0 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM